|Bid||46.50 x 0|
|Ask||47.00 x 0|
|Day's Range||44.00 - 47.32|
|52 Week Range||31.00 - 153.00|
|Beta (5Y Monthly)||1.01|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 17, 2021 - May 21, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||70.00|
If you want to know who really controls Shield Therapeutics plc ( LON:STX ), then you'll have to look at the makeup of...
We feel now is a pretty good time to analyse Shield Therapeutics plc's ( LON:STX ) business as it appears the company...
Even if it's not a huge purchase, we think it was good to see that Timothy Watts, the CEO & Director of Shield...